Hims & Hers Health (HIMS) Stock: Menopause Care Launch Drives 12% Rally

TLDR Hims & Hers stock jumped 12-16% on October 15 after launching a new menopause and perimenopause care program on its Hers platform. The stock is trading around $62.80, up roughly 110-115% year-to-date in 2025, vastly outperforming competitors like Teladoc which is down 44%. The FDA criticized Hims in September for a Super Bowl ad [...]

The post Hims & Hers Health (HIMS) Stock: Menopause Care Launch Drives 12% Rally appeared first on Blockonomi.